Tova Stram Ablove, M.D.


Dr. Ablove is a fellowship-trained physician who utilizes the most advanced state-of-the-art diagnostics and treatments to provide relief for women with incontinence, prolapse, lower urinary tract disease and conditions related to aging of the pelvic floor.

She was recently recognized as a Top Doctor in Western New York by Castle Connolly’s surveying and research methods. View the Buffalo Spree article here.

As a specialist in the area of female pelvic medicine and reconstructive surgery, Dr. Ablove focuses her clinical practice on comprehensive care of women with pelvic floor disorders. This includes urinary incontinence, pelvic organ prolapse, including cystoceles and rectoceles, some types of fecal incontinence and painful bladder syndrome. She is also experienced in treating conditions associated with geriatric gynecology and menopause, with a special focus on incontinence, aging of the pelvic floor and associated diseases. These patients are typically beyond child-bearing age and often have one or more disorders associated with the primary condition.

In addition to treating patients, Dr. Ablove enjoys teaching and conducting research. As an Associate Professor at the University at Buffalo, she has opportunities to mentor medical students and residents and to conduct clinical, translational and basic research. She has a strong interest in collaborating with other specialties and disciplines to seek out holistic, multidisciplinary solutions for her patients.

Associate Professor, CHS

Dr. Tova Ablove is an experienced physician and researcher specializing in gynecology, female pelvic medicine and reconstructive pelvic surgery.


  • State University of New York at Buffalo School of Medicine and Biomedical Sciences – Doctor of Medicine, specializing in Obstetrics and Gynecology (1996)
  • Roswell Park Cancer Institute, SUNY at Buffalo – Post-Grad in Biophysics (1992)
  • State University of New York at Buffalo School of Medicine and Biomedical Sciences – Bachelor of Science, Physics (1991)


  • Obstetrics and Gynecology, Albany Medical Center, NY (1996 – 2000)


  • Urogynecology and Reconstructive Pelvic Surgery, Albany Medical Center/Northeast Urogynecology, NY (2000 – 2003)


  • Sigma Pi Sigma National Honor Society, State University of New York College at Buffalo in recognition of high scholarship in Physics (1990)
  • Graduated Cum Laude, State University of New York College at Buffalo (1991)

Professional Experience

  • Associate Professor, CHS (August 2015 – Present)
  • University at Buffalo Department of Obstetrics and Gynecology, Assistant Professor (September 2013 – July 2015)
  • University of Wisconsin Department of Obstetrics and Gynecology, Assistant Professor, CHS (September 2003 – July 2013)
  • Albany Medical Center Limited Clinical Practitioner, Obstetrics (September 2000 – September 2001)

Journal Reviewer

As a recognized expert in urogynecological diagnosis and treatment, Dr. Ablove is a submission reviewer for the following publications and programs:

  • UroToday International Journal
  • Clinical Medicine & Research
  • Institute for Clinical and Translational Research (ICTR) KL2 Program application


Dr. Ablove is also an active member of various industry committees, councils, societies and associations:

  • University at Buffalo Faculty Council
  • ACOG District 2 Legislative Committee
  • American Urogynecologic Society
  • International Continence Society
  • International Urogynecological Association
  • Buffalo Gynecologic and Obstetric Society


Dr. Ablove is very active in writing papers on various urogynecological topics for publication, and has given talks and presentations throughout the United States. She is also engaged in grant-funded research as principal investigator on:

  • The effects of endogenous ovarian estrogen vs. exogenous estrogen replacement on blood flow and estrogen receptor levels in the bladder (Completed)
  • Open label single arm clinical trial evaluating the safety and efficacy of using Solfinacin (an anticholinergic medication) to treat post-void dribbling (Completed)
  • An investigator initiated randomized controlled trial evaluating the effect of Solfiacin (an anticholinergic medication) on post-void dribbling symptoms (Ongoing)
  • Two additional extramural funding opportunities in the beginning stages of contract negotiations with the University at Buffalo